Published in Ann Surg on September 01, 1999
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer | NCT01174121
Simultaneous Resection of Colorectal Cancer With Synchronous Liver Metastases (RESECT) | NCT02954913
MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) | NCT05189171
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Quality of complication reporting in the surgical literature. Ann Surg (2002) 4.21
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Epidemiology and management of liver metastases from colorectal cancer. Ann Surg (2006) 3.37
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05
Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg (2002) 2.84
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut (2005) 2.82
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg (2006) 2.70
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Liver resection for colorectal metastases: the third hepatectomy. Ann Surg (2003) 2.57
Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg (2004) 2.49
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg (2001) 2.40
Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg (2005) 2.38
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg (2008) 2.38
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33
The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg (2007) 2.23
A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20
Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg (2006) 2.17
Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg (2008) 2.15
Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer. World J Surg (2013) 2.12
Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors. Surg Endosc (2012) 2.04
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Cancer (2013) 1.94
Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol (2009) 1.83
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) (2011) 1.82
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J Clin Oncol (2010) 1.80
Hepatic resection for metastatic tumors from gastric cancer. Ann Surg (2002) 1.79
An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg (2005) 1.76
The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist (2012) 1.76
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol (2012) 1.69
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg (2004) 1.65
Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol (2011) 1.63
Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg (2000) 1.62
Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut (2003) 1.61
Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg (2005) 1.60
Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg (2013) 1.58
Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases. World J Surg (2010) 1.52
Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg (2007) 1.52
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making. Ann Surg Oncol (2012) 1.50
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol (2009) 1.50
Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. JAMA Surg (2015) 1.46
Metastatic tumors in the pancreas in the modern era. J Am Coll Surg (2010) 1.45
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford) (2011) 1.44
Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg (2002) 1.42
Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg (2005) 1.41
Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg (2006) 1.38
Current treatment for colorectal liver metastases. World J Gastroenterol (2011) 1.38
RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg (2013) 1.34
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer (2014) 1.32
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol (2012) 1.30
Current treatment for liver metastases from colorectal cancer. World J Gastroenterol (2003) 1.28
Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg (2004) 1.28
Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg (2004) 1.27
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer (2008) 1.26
Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol (2014) 1.26
Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol (2012) 1.24
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer (2007) 1.21
Preoperative imaging for hepatic resection of colorectal cancer metastasis. J Gastrointest Oncol (2012) 1.20
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib. Int J Radiat Oncol Biol Phys (2014) 1.18
Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg (2008) 1.18
Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery (2011) 1.17
Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer (2007) 1.16
Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg (2010) 1.15
Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg (2013) 1.14
Role of surgery in colorectal cancer liver metastases. World J Gastroenterol (2014) 1.13
What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) (2010) 1.12
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer (2007) 1.12
Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg (2002) 1.12
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One (2012) 1.11
The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg (2007) 1.11
Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg (2013) 1.10
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) (2013) 1.08
The biology and treatment of oligometastatic cancer. Oncotarget (2015) 1.08
Radical irradiation of extracranial oligometastases. J Clin Oncol (2014) 1.07
Actual role of radiofrequency ablation of liver metastases. Eur Radiol (2007) 1.07
Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol (2013) 1.07
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2012) 1.07
Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol (2005) 1.06
CASH (Chemotherapy-Associated Steatohepatitis) costs. Ann Surg (2006) 1.06
Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients? World J Surg (2005) 1.06
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? Ann Surg (2015) 1.06
The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status. Int J Colorectal Dis (2007) 1.05
A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival. Clin Cancer Res (2010) 1.05
Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer (2007) 1.05
Treatment of colorectal liver metastases. World J Surg Oncol (2011) 1.04
Metastatic colorectal cancer-past, progress and future. World J Gastroenterol (2007) 1.04
New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res (2007) 1.03
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet (1998) 5.65
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet (1957) 4.66
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35
Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet (1968) 3.33
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97
Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg (1987) 2.58
Survival after liver resection for secondary tumors. Am J Surg (1978) 2.57
One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg (1991) 2.55
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg (1987) 2.54
Hepatic ablation using radiofrequency electrocautery. Invest Radiol (1990) 2.38
Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet (1986) 2.21
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10
Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol (1990) 2.07
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg (1991) 1.79
Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J (1999) 1.64
The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg (1996) 1.64
[Anatomic principles of left and right regulated hepatectomy: technics]. J Chir (Paris) (1954) 1.62
Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer (1985) 1.61
Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg (1989) 1.55
The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol (1991) 1.53
Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet (1987) 1.37
Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. J Clin Invest (1997) 1.22
p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases. J Clin Oncol (1996) 1.20
Australian experience of cryoablation of liver tumors: metastases. Surg Oncol Clin N Am (1996) 1.14
Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. J Nucl Med (1996) 1.13
A technique for the use of cryosurgery to assist hepatic resection. J Am Coll Surg (1995) 1.13
A new technique for hepatic infusional chemotherapy. Semin Surg Oncol (1986) 1.07
Radioimmunodetection of hepatic metastases from human colon cancer in nude mice with a gamma-detecting probe. Cancer Res (1990) 1.07
A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters. J Neurosci Methods (1991) 1.04
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24
Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Is duodenitis a dyspeptic myth? Lancet (1977) 6.17
Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg (1993) 6.15
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg (1995) 5.90
Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg (1998) 5.87
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18
A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg (1978) 3.91
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol (1996) 3.85
Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg (2000) 3.06
Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg (1998) 3.04
Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg (1990) 3.01
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98
Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg (1998) 2.97
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90
Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula. Br J Surg (1990) 2.89
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg (1984) 2.78
The National Cancer Data Base report on pancreatic cancer. Cancer (1995) 2.77
Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol (1993) 2.71
Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65
Soft tissue sarcomas. Curr Probl Surg (1996) 2.62
Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60
Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer (1989) 2.57
The enigma of desmoid tumors. Ann Surg (1999) 2.57
Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57
Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg (1999) 2.57
Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol (2000) 2.48
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg (2000) 2.43
A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol (1976) 2.42
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Recent advances in the management of cholangiocarcinomas. Semin Liver Dis (1994) 2.30
Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol (1999) 2.30
Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet (1984) 2.28
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol (2008) 2.12
Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol (1997) 2.10
Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg (1999) 2.09
Cannulation of papilla of vater via fiber-duodenoscope. Assessment of retrograde cholangiopancreatography in 60 patients. Lancet (1972) 2.09
Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg (1993) 2.07
Percutaneous transhepatic drainage in obstructive jaundice: advantages and problems. Br J Surg (1982) 2.07
Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06
Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann Surg (1984) 2.06
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06
Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg (2000) 2.05
Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03
Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer (1999) 2.03
One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg (1994) 2.03
Surgical management of intra-abdominal desmoid tumours. Br J Surg (2000) 2.01
Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg (1995) 1.99
Management of 155 patients with benign liver tumours. Br J Surg (2001) 1.97
Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg (1996) 1.97
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Per-operative cholangiography and post-cholecystectomy biliary strictures. Ann R Coll Surg Engl (1985) 1.95
Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination. Arch Surg (1993) 1.94
Adult urological sarcoma. J Urol (1992) 1.94
Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg (1992) 1.92
Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91
Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.90
High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery (1997) 1.89
Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg (2000) 1.88
Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86
Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg (2000) 1.85
Radiation-associated sarcoma of bone and soft tissue. Arch Surg (1992) 1.84
Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol (2000) 1.83
Useful stapling techniques in liver surgery. J Am Coll Surg (1997) 1.83
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol (2004) 1.80
Effect of reresection in extremity soft tissue sarcoma. Ann Surg (2000) 1.80
Uncomplicated starvation versus cancer cachexia. Cancer Res (1977) 1.79
Outcome of radical surgery in hilar cholangiocarcinoma. Surgery (1990) 1.79
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg (1991) 1.79
Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg (1991) 1.79
Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer (2000) 1.78
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol (1997) 1.77
Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol (1997) 1.75
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol (1999) 1.75
Carcinoma in choledochal cysts. Age-related incidence. Arch Surg (1983) 1.75
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75